Arkolith/Insider Trading/CRNX/Form 4

Struthers Richard Scott

President & CEO, DirectorCrinetics Pharmaceuticals, Inc. (CRNX) · full profile →Form 4 · filed Jun 2, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
14
14 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 29, 2026Gift(G)222K—$0439K
May 29, 2026Gift(G)222K—$0217K
May 29, 2026Gift(G)80K—$0137K
May 29, 2026Gift(G)222K—$0627K
May 29, 2026Gift(G)222K—$0223K
May 29, 2026Gift(G)80K—$080K
May 29, 2026Gift(G)111K—$0516K
May 29, 2026Gift(G)111K—$0405K
May 29, 2026Gift(G)111K—$0111K
May 29, 2026Gift(G)111K—$0111K
May 29, 2026Gift(G)111K—$0112K
May 29, 2026Gift(G)111K—$01K
May 29, 2026Gift(G)111K—$0111K
May 29, 2026Gift(G)111K—$0111K

Transaction Codes

G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-039784) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML